Allison Aubrey
Allison Aubrey is a correspondent for NPR News, where her stories can be heard on Morning Edition and All Things Considered. She's also a contributor to the PBS NewsHour and is one of the hosts of NPR's Life Kit.
Along with her NPR science desk colleagues, Aubrey is the winner of a 2019 Gracie Award. She is the recipient of a 2018 James Beard broadcast award for her coverage of 'Food As Medicine.' Aubrey is also a 2016 winner of a James Beard Award in the category of "Best TV Segment" for a PBS/NPR collaboration. The series of stories included an investigation of the link between pesticides and the decline of bees and other pollinators, and a two-part series on food waste. In 2013, Aubrey won a Gracie Award with her colleagues on The Salt, NPR's food vertical. They also won a 2012 James Beard Award for best food blog. In 2009, Aubrey was awarded the American Society for Nutrition's Media Award for her reporting on food and nutrition. She was honored with the 2006 National Press Club Award for Consumer Journalism in radio and earned a 2005 Medical Evidence Fellowship by the Massachusetts Institute of Technology and the Knight Foundation. In 2009-2010, she was a Kaiser Media Fellow.
Joining NPR in 2003 as a general assignment reporter, Aubrey spent five years covering environmental policy, as well as contributing to coverage of Washington, D.C., for NPR's National Desk. She also hosted NPR's Tiny Desk Kitchen video series.
Before coming to NPR, Aubrey was a reporter for the PBS NewsHour and a producer for C-SPAN's Presidential election coverage.
Aubrey received her Bachelor of Arts degree from Denison University in Granville, Ohio, and a Master of Arts degree from Georgetown University in Washington, D.C.
-
FDA vaccine advisers will meet Tuesday to review data on Pfizer's COVID-19 vaccine for children ages 5-11. A Pfizer study found the vaccine is 91% effective at preventing symptomatic infections.
-
Pfizer-BioNTech says their COVID-19 vaccine is 90% effective in kids ages 5 to 11. The Food and Drug Administration is likely to decide on emergency authorization as soon as the last week of October.
-
The FDA has issued new targets to reduce the amount of salt that manufacturers put in their foods. It could prevent thousands of cases of cardiovascular disease. -
The FDA gave permission for the sale of a brand of e-cigarettes — saying the product can help adult quit smoking. At the same time, it rejected many flavored products which are popular with teens.
-
The FDA has authorized the marketing of a line of e-cigarettes made by the R.J. Reynolds Vapor Company. The tobacco-flavored products can help adults quit smoking regular tobacco cigarettes.
-
The FDA will review booster data from Moderna and J&J. A preview of what to expect from the FDA this week, and how vaccines are still holding up despite waning immunity.
-
The COVID surge is ebbing though deaths remain high. Meanwhile, the FDA has set a date to review data on vaccines for kids under 12 and the NIH has launched long-hauler study.
-
New COVID-19 cases dropped by 20% over the last two weeks. There's optimism this downward trend could continue. At the same time, millions of Americans are eligible for a Pfizer booster shot.
-
An independent advisory committee of the CDC is evaluating the need for a Pfizer booster dose — meeting one day after the FDA granted emergency use authorization for a booster dose in certain adults.
-
The Food and Drug Administration gave the OK for a Pfizer COVID-19 vaccine booster for anyone 65 or older or at high risk for severe disease. People whose work puts them at risk will also be eligible.
-
A smaller dose of Pfizer's COVID-19 vaccine is safe and effective for children ages 5 to 11, according to data the company released Monday. The data will now go before the FDA and CDC for review.
-
The U.S. is averaging about 140,000 new cases of coronavirus per day and about 1,500 people are dying each day from the virus. Amid this surge, the Biden administration's booster strategy is in flux.
